| Today, Tue, Nov 10, 2009 | | • | Bristol Licenses Arthritis Drug: BioBuzz
at TheStreet.com (Tue 9:20am)
| | • | ETF Picks: Consider This Diversified Partial Portfolio
at Minyanville.com (Tue 9:10am)
| | • | Celgene in the ASH Abstract Spotlight: BioBuzz
at TheStreet.com (Tue 6:31am)
| | • | Celgene in ASH Abstract Spotlight: BioBuzz
at TheStreet.com (Tue 6:31am)
| | Mon, Nov 9, 2009 | | • | Bulls Buy Cephalon, WebMD:Options Recap
at TheStreet.com (Mon 4:17pm)
| | • | Monday Options Update: GLD, AMR, ANF, CEPH & ESV
at Seeking Alpha (Mon 1:04pm)
| | • | Top 10 Stocks for Obamacare
at CNBC (Mon 8:25am)
| | Sun, Nov 8, 2009 | | • | Cephalon's Upside and Downside
at Seeking Alpha (Sun, Nov 8)
| | Fri, Nov 6, 2009 | | • | Specialty Pharma Stock Picks From David Amsellem Of Piper Jaffray
Wall Street Transcript (Fri, Nov 6)
| | Thu, Nov 5, 2009 | | • | Alkermes takes 2Q loss, cuts full-year estimates
AP (Thu, Nov 5)
| | • | King Beats, but Earnings Down
Zacks.com (Thu, Nov 5)
| | • | 5-Star Stocks on the Upswing
at Motley Fool (Thu, Nov 5)
| | • | Indian Pharmaceutical Stock Picks From Citi Investment Research: The Sub Continent Goes Global WIth Drug Manufacturing Partnerships
Wall Street Transcript (Thu, Nov 5)
| | • | Pivotal Data Published in the Journal Cancer Demonstrate that TREANDA Induced Durable Responses in Relapsed Indolent Non-Hodgkin's Lymphoma
PR Newswire (Thu, Nov 5)
| | Wed, Nov 4, 2009 | | • | CEPHALON INC Files SEC form 8-K, Other Events
EDGAR Online (Wed, Nov 4)
| | • | Cephalon, Inc. to Webcast R&D Day
PR Newswire (Wed, Nov 4)
| | Tue, Nov 3, 2009 | | • | SPDR Trust, Cephalon: Money Flow Leaders (SPY, CEPH)
at The Wall Street Journal Online (Tue, Nov 3)
| | Mon, Nov 2, 2009 | | • | Award Winning Piper Jaffrey Analyst Sees Transkaryotic Therapeutics Acquisition Paying Off For Shire With Early 2010 Approval Of Velaglucerase
Wall Street Transcript (Mon, Nov 2)
| | • | Mayo Clinic Proceedings Publishes Study of NUVIGIL in Patients with Shift Work Disorder
PR Newswire (Mon, Nov 2)
| | • | CEO Interview, Cortex Pharmaceuticals, Inc. - Dr. Mark Varney
Wall Street Transcript (Mon, Nov 2)
|
Add CEPH News to My Yahoo!:
 
| |
|
0.12% Nasdaq 
0.10%
Headlines
